Get started
Author

Miao Zheng

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies
2019 · Na Wang, Xuelian Hu, et al. · Blood · 264
PDF
CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas
2021 · Yang Cao, Yi Xiao, et al. · Transplantation and Cellular Therapy · 65
PDF
Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma
2020 · Zaisheng Ye, Miao Zheng, et al. · Frontiers in Genetics · 47
A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma
2021 · Zaisheng Ye, Miao Zheng, et al. · Frontiers in Oncology · 36
PDF
Clinical and genetic characterization of Epstein-Barr virus–associated T/NK-cell lymphoproliferative diseases
2022 · Hui Luo, Dan Liu, et al. · Journal of Allergy and Clinical Immunology · 32
The selective distribution of LYVE-1-expressing endothelial cells and reticular cells in the reticulo-endothelial system (RES)
2016 · Miao ZHENG, Shunsuke KIMURA, et al. · Biomedical Research · 32
PDF
Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
2019 · Miao Zheng, Yanlin Zheng, et al. · Experimental and Therapeutic Medicine · 25
PDF
The superiority of Epstein‐Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV‐positive NK‐cell lymphoproliferative diseases
2022 · Miao Zheng, Yuhan Bao, et al. · Hematological Oncology · 24
Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis
2023 · Yaxian Ma, Peiling Zhang, et al. · Frontiers in Immunology · 22
Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma
2021 · Zai-Sheng Ye, Miao Zheng, et al. · World Journal of Gastroenterology · 22
Three types of macrophagic cells in the mesentery of mice with special referenceto LYVE-1-immunoreactive cells
2014 · Miao ZHENG, Shunsuke KIMURA, et al. · Biomedical Research · 20
PDF
Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma
2022 · Jiaying Wu, Yang Cao, et al. · Frontiers in Immunology · 16
PDF
Efficacy of programmed cell death 1 inhibitor maintenance after chimeric antigen receptor T cells in patients with relapsed/refractory B-cell non-Hodgkin-lymphoma
2024 · Xiangke Xin, Xiaojian Zhu, et al. · Cellular Oncology · 15
Characteristics of IgG subclasses and complement deposition in BP 230‐type bullous pemphigoid
2018 · M. Zheng, H. Ujiie, et al. · Journal of the European Academy of Dermatology and Venereology · 15
Regulatory T cell subsets in bullous pemphigoid and dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid
2020 · Ken Muramatsu, Miao Zheng, et al. · Journal of Dermatological Science · 14
Case Report: Active tuberculosis infection in CAR T-cell recipients post CAR T-cell therapy: a retrospective case series
2023 · Peiling Zhang, Liang Huang, et al. · Frontiers in Cellular and Infection Microbiology · 10
PDF
A novel type of cells expressing GP2 in the respiratory epithelium of the paranasal sinuses in mice
2014 · Shunsuke KIMURA, Mami MUTO, et al. · Biomedical Research · 10
PDF
Case Report: Post-CAR-T Infusion HBV Reactivation in Two Lymphoma Patients Despite Entecavir Preventive Therapy
2021 · Yaxian Ma, Li Yang, et al. · Frontiers in Immunology · 9
PDF
A possible association between BP230-type bullous pemphigoid and dementia: a report of two cases in elderly patients
2017 · M. Zheng, H. Ujiie, et al. · British Journal of Dermatology · 8
Bortezomib-based chemotherapy regimens can improve response in newly diagnosed multiple myeloma patients with bcl-2 and survivin overexpression.
2014 · Wen Zeng, Fankai Meng, et al. · PubMed Central · 8
Clinical and genetic features of Epstein‐Barr virus‐triggered late‐onset primary hemophagocytic lymphohistiocytosis: Ten pedigrees study
2021 · Lili Gao, Li Yang, et al. · Clinical and Translational Medicine · 7
PDF
TP53-Mutated Circulating Tumor DNA for Disease Monitoring in Lymphoma Patients after CAR T Cell Therapy
2021 · Liting Chen, Wei Mu, et al. · Diagnostics · 6
PDF
Immunohistochemical localization of fatty acid transporters and MCT1 in the sebaceous glands of mouse skin
2016 · Miao ZHENG, Shinhye LEE, et al. · Biomedical Research · 6
PDF
Combination of chidamide and PD-1 blockade in Refractory/Relapsed aggressive large B-cell lymphomas with high risk of failing CAR-T therapy
2024 · Zhenhao Wang, Hao Xu, et al. · International Immunopharmacology · 5
Epstein–Barr virus-associated B-cell lymphoproliferative disorder meeting the definition of CAEBV B cell disease: a case report
2023 · Yaxian Ma, Yuhan Bao, et al. · BMC Infectious Diseases · 5
PDF
Works count: 72
Citation count: 770
H-index: 14
I10-index: 17
Year
Topic
Type